Vladimir Gilca

Summary

Country: Canada

Publications

  1. ncbi Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine
    Vladimir Gilca
    Institut National de Sante Publique du Quebec, Laval University, Quebec, Canada
    Hum Vaccin 6:212-8. 2010
  2. ncbi Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine
    Vladimir Gilca
    Institut National de Sante Publique du Quebec, Universite Laval, Quebec, Canada
    Vaccine 31:448-51. 2013
  3. ncbi Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children
    Vladimir Gilca
    Quebec Public Health Institute, Canada
    Vaccine 30:35-41. 2011
  4. ncbi A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign
    Eve Dube
    Institut National de Sante Publique du Quebec, 2400 d Estimauville, Quebec, Canada
    BMC Public Health 11:128. 2011
  5. ncbi Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis
    Andrea C Tricco
    Li Ka Shing Knowledge Institute, St Michael s Hospital, 38 Shuter Street, Toronto, Ontario, M5B 1T8, Canada
    BMC Infect Dis 11:235. 2011
  6. ncbi Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review
    Ba Pham
    Biomedical Data Sciences, GlaxoSmithKline, Ontario, Canada
    BMC Infect Dis 5:56. 2005
  7. ncbi Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A
    Arni S R Srinivasa Rao
    Department of Mathematics and Statistics, University of Guelph, Guelph, Canada
    BMC Infect Dis 6:174. 2006
  8. ncbi A review of interventions triggered by hepatitis A infected food-handlers in Canada
    Andrea C Tricco
    Epidemiology and Biostatistics, GlaxoSmithKline Canada, Mississauga, Ontario, Canada
    BMC Health Serv Res 6:157. 2006
  9. ncbi Setting priorities for new vaccination programs by using public health officers and immunization managers opinions
    Vladimir Gilca
    Institut National de Sante Publique du Quebec, Laval University Research Hospital Center, Quebec, Canada
    Vaccine 26:4204-9. 2008
  10. ncbi Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later
    Vladimir Gilca
    Institut National de Sante Publique du Quebec, Laval University, Quebec, Canada
    Vaccine 27:6048-53. 2009

Collaborators

Detail Information

Publications25

  1. ncbi Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine
    Vladimir Gilca
    Institut National de Sante Publique du Quebec, Laval University, Quebec, Canada
    Hum Vaccin 6:212-8. 2010
    ..70-0.90). Three doses of RB administered at the age of 8-10 years induce a 10 years long-lasting immunity in virtually all vaccinees. The booster does not appear necessary on a 10 years perspective...
  2. ncbi Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine
    Vladimir Gilca
    Institut National de Sante Publique du Quebec, Universite Laval, Quebec, Canada
    Vaccine 31:448-51. 2013
    ..These results do not support the need of a booster for at least 15 years when vaccinating preadolescents with Engerix-B...
  3. ncbi Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children
    Vladimir Gilca
    Quebec Public Health Institute, Canada
    Vaccine 30:35-41. 2011
    ..In 2009, several countries used the ASO3-adjuvanted pandemic A/H1N1 vaccine. We assessed the persistence of antibody and the priming induced by a single paediatric dose of this vaccine in children...
  4. ncbi A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign
    Eve Dube
    Institut National de Sante Publique du Quebec, 2400 d Estimauville, Quebec, Canada
    BMC Public Health 11:128. 2011
    ....
  5. ncbi Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis
    Andrea C Tricco
    Li Ka Shing Knowledge Institute, St Michael s Hospital, 38 Shuter Street, Toronto, Ontario, M5B 1T8, Canada
    BMC Infect Dis 11:235. 2011
    ..Oncogenic human papillomavirus (HPV) infection prevalence is required to determine optimal vaccination strategies. We systematically reviewed the prevalence of oncogenic cervical HPV infection among Canadian females prior to immunization...
  6. ncbi Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review
    Ba Pham
    Biomedical Data Sciences, GlaxoSmithKline, Ontario, Canada
    BMC Infect Dis 5:56. 2005
    ..This systematic review aimed to 1) estimate age-specific prevalence of HAV antibody in Canada and 2) evaluate infection-associated risk factors...
  7. ncbi Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A
    Arni S R Srinivasa Rao
    Department of Mathematics and Statistics, University of Guelph, Guelph, Canada
    BMC Infect Dis 6:174. 2006
    ..As a result, age-stratified seroprevalence profiles often differ from what would be expected from constant infection rates...
  8. ncbi A review of interventions triggered by hepatitis A infected food-handlers in Canada
    Andrea C Tricco
    Epidemiology and Biostatistics, GlaxoSmithKline Canada, Mississauga, Ontario, Canada
    BMC Health Serv Res 6:157. 2006
    ..We undertook a systematic review of such incidents to evaluate the extent of viral transmission through food contamination and the scope of post-exposure prophylaxis (PEP) interventions...
  9. ncbi Setting priorities for new vaccination programs by using public health officers and immunization managers opinions
    Vladimir Gilca
    Institut National de Sante Publique du Quebec, Laval University Research Hospital Center, Quebec, Canada
    Vaccine 26:4204-9. 2008
    ..The method we propose is flexible in choosing target groups and allows a large number of professionals to be involved in the decision-making process about new immunization programs...
  10. ncbi Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later
    Vladimir Gilca
    Institut National de Sante Publique du Quebec, Laval University, Quebec, Canada
    Vaccine 27:6048-53. 2009
    ..The excellent anamnestic response observed after the booster dose demonstrates the persistence of immunity in virtually all young adults vaccinated at the age of 8-10 with three paediatric doses of Engerix-B...
  11. ncbi Attitudes of nurses toward current and proposed vaccines for public programs: a questionnaire survey
    Vladimir Gilca
    Quebec Public Health Institute, Canada
    Int J Nurs Stud 46:1219-35. 2009
    ..Little is known about nurses' perceived usefulness of recommended vaccines and no recent study has assessed nurses' opinions regarding new candidate vaccines for the public programs...
  12. ncbi Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program
    Vladimir Gilca
    Institut National de Sante Publique du Quebec, Canada
    Pediatr Infect Dis J 25:372-4. 2006
    ..The preteen vaccination program is highly effective. An infant immunization program would bring additional benefits...
  13. ncbi Long-term immunogenicity of two pediatric doses of combined hepatitis A and B or monovalent hepatitis B vaccine in 8 to 10-year-old children and the effect of a challenge dose given seven years later
    Vladimir Gilca
    Quebec National Public Health Institute, Quebec, Canada
    Pediatr Infect Dis J 28:916-8. 2009
    ..All vaccinees in the TX and 98% in the RB group showed an anamnestic response. Vaccination at the age of 8 to 10 years with two-pediatric doses of TX or RB given with a 6 months interval induces a long-lasting immunity in most vaccinees...
  14. ncbi Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country
    Bernard Duval
    Institut National de Sante Publique du Quebec, Quebec, Canada
    Pediatr Infect Dis J 24:213-8. 2005
    ..The long term effect of the booster dose in teenagers is unknown. We evaluated the immunogenicity of 2 pediatric hepatitis vaccines after primary vaccination and after a booster dose...
  15. ncbi Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children
    Bernard Duval
    Institut National de Sante Publique du Quebec, Quebec, Canada
    Vaccine 23:4082-7. 2005
    ..This schedule could facilitate a greater vaccine acceptance and the addition of hepatitis A vaccine to existing adolescent universal hepatitis B virus immunization programs...
  16. ncbi Acute otitis media and its prevention by immunization: a survey of Canadian pediatricians' knowledge, attitudes and beliefs
    Eve Dube
    Institut National de Sante Publique du Quebec, Quebec, Canada
    Hum Vaccin 7:429-35. 2011
    ..The main aim of this study was to assess pediatricians' opinions regarding AOM and its prevention by immunization...
  17. ncbi Cervical cancer prevention by vaccination: nurses' knowledge, attitudes and intentions
    Bernard Duval
    Quebec National Public Health Institute, Canada
    J Adv Nurs 65:499-508. 2009
    ....
  18. ncbi New vaccines offering a larger spectrum of protection against acute otitis media: will parents be willing to have their children immunized?
    Eve Dube
    Quebec National Institute of Public Health, Quebec, Canada
    Int J Pediatr Otorhinolaryngol 73:987-91. 2009
    ..To examine parents' knowledge, attitudes and beliefs regarding acute otitis media (AOM) and parents' willingness to vaccinate their children with new vaccine offering larger spectrum of protection against AOM...
  19. ncbi Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs
    Bernard Duval
    Institut National de Sante Publique du Quebec, Laval University Research Hospital Center, Quebec, Canada
    Vaccine 25:7841-7. 2007
    ..7%). To achieve high rates of vaccination coverage, several modifiable factors should be taken in consideration during immunization program implementation...
  20. ncbi Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada
    Chantal Sauvageau
    Quebec Regional Public health department, Health and Social Services Agency, Quebec, Canada
    BMC Public Health 7:304. 2007
    ..The study had two objectives: 1) To assess practices, beliefs, and attitudes regarding Pap test screening and HPV immunization; 2) To identify socio-demographic factors for Pap screening and vaccine acceptability...
  21. ncbi Trends of hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003
    Magalie Canuel
    Department of Social and Preventive Medicine, Laval University, Quebec, Canada
    BMC Infect Dis 7:31. 2007
    ..This study estimated the year and age specific hospitalization rates and distribution of risk factors for HA in Quebec, Canada, between 1990 and 2003...
  22. ncbi Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A(H1N1) pandemic vaccine
    Eve Dube
    Centre de Recherche du CHUL CHUQ, Centre hospitalier de l Universite Laval, Quebec, Canada
    BMC Res Notes 3:102. 2010
    ....
  23. ncbi Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old
    Bernard Duval
    Institut National de Sante Publique du Quebec, Canada
    Pediatr Infect Dis J 24:514-9. 2005
    ..Consequently we do not know the incidence of infection in children and what would be the most appropriate age for hepatitis A vaccination...
  24. ncbi Burden of acute otitis media on Canadian families
    Eve Dube
    Quebec National Institute of Public Health, Quebec, QC
    Can Fam Physician 57:60-5. 2011
    ..To estimate the burden of acute otitis media (AOM) on Canadian families...
  25. ncbi The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains
    Rodica Gilca
    Institut National de Sante Publique du Quebec, Quebec City, Quebec, Canada
    PLoS ONE 7:e50659. 2012
    ....